EUVIMEDEUVIMED entdecken
Crossref

Pilot trial evaluating Arrabidaea chica gel’s therapeutic effect on oral mucositis in head and neck cancer patients undergoing treatment

N de Cássia Almeida Queiroz, M P Jorge, I M de Oliveira Sousa, A C Brito Maria, CS P Lima, E B Pereira, J E de Carvalho, T F Galvao, M A Foglio

Planta Medica · 01.03.2026 · 92 (03) · 379-380

DOI: 10.1055/s-0045-1815349 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.03.2026. Verfasst von N de Cássia Almeida Queiroz und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oral mucositis is a common side effect in patients with head and neck cancer who require treatments with effective outcomes [ 1 ]. The management of this condition remains limited and is primarily palliative [ 2 ]. Arrabidaea chica demonstrates a safe healing potential by stimulating fibroblast proliferation, enhancing collagen synthesis, and exhibiting antioxidant activity without associated toxicity [ 3 ] [ 4 ] [ 5 ]. This randomized controlled trial aimed to evaluate the therapeutic effect of a mucoadhesive gel containing 2.5% Arrabidaea chica extract in patients diagnosed with oral mucositis resulting from head and neck squamous cell carcinoma, in comparison to treatment with low-intensity laser therapy. The study was designed as a randomized, parallel, open-label clinical trial and was approved by the Research Ethics Committee of the Faculty of Medical Sciences at the University of Campinas (CAAE: 55933516.3.0000.5404).The control group received an 808-nm infrared low-intensity laser in lesion areas during 40 s and the intervention group; treatment received A. chica gel three times per day. Mucositis data outcome considered time in days, pain assessment by a visual analogue scale. The control group comprised five participants treated with low-intensity laser, with the intervention group encompassing six participants. The groups treated with laser and 2.5% A. chica gel showed a 2.4±1.9 and 3.3±3.4 (p=0.605) pain scores, respectively. Trial outcome gave for laser and A. chica gel an average of 16.4±8.6 and 9.2±3.1 (p=0.085) days to heal. The study was discontinued due to difficulties in recruiting volunteers. The patients only visited the hospital to receive antineoplastic therapy. Publication History Article published online: 05 March 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

Zitieren

APA

Queiroz, N. D. C. A., Jorge, M. P., Sousa, I. M. D. O., Maria, A. C. B., Lima, C. P., Pereira, E. B., Carvalho, J. E. D., Galvao, T. F., & Foglio, M. A. (2026). Pilot trial evaluating Arrabidaea chica gel’s therapeutic effect on oral mucositis in head and neck cancer patients undergoing treatment. Planta Medica, 92(03), 379-380. https://doi.org/10.1055/s-0045-1815349

Vancouver

Queiroz NDCA, Jorge MP, Sousa IMDO, Maria ACB, Lima CP, Pereira EB, et al. Pilot trial evaluating Arrabidaea chica gel’s therapeutic effect on oral mucositis in head and neck cancer patients undergoing treatment. Planta Medica. 2026;92(03):379-380. doi:10.1055/s-0045-1815349

BibTeX
@article{Queiroz2026,
  author = {Queiroz, N de Cássia Almeida and Jorge, M P and Sousa, I M de Oliveira and Maria, A C Brito and Lima, CS P and Pereira, E B and Carvalho, J E de and Galvao, T F and Foglio, M A},
  title = {Pilot trial evaluating Arrabidaea chica gel’s therapeutic effect on oral mucositis in head and neck cancer patients undergoing treatment},
  journal = {Planta Medica},
  year = {2026},
  volume = {92},
  number = {03},
  pages = {379--380},
  doi = {10.1055/s-0045-1815349}
}
Kostenlos starten →